Age Related Eye Disease Study
AREDS VitaminsThis major clinical trial sponsored by the National Institute of Health began in September 1990 and the first results were published in a press release in 2001. The study involved:
√ those whose macular status ranged from no evidence of age related macular degeneration (AMD) in either eye to relatively severe disease with vision loss in one eye but good vision in the fellow eye (20/30 or better) √ being followed for 5 years √ being given one of four treatments: 1) zinc alone 2) antioxidants alone 3) a combination of antioxidants and zinc 4) a placebo, a harmless substance that has no medical effect. The results stated that the AREDS "found that taking high levels of antioxidants and zinc can reduce the risk of developing advanced age-related macular degeneration (AMD) by about 25 percent." NIH News Release Friday, October 12, 2001 AREDS Formula
The nutrients in the AREDS contained:500 milligrams of vitamin C 400 international units of vitamin E 15 milligrams of beta-carotene 80 milligrams of zinc as zinc oxide and two milligrams of copper as cupric oxide (Copper was added to the AREDS formulations containing zinc to prevent copper deficiency, which may be associated with high levels of zinc supplementation). Bausch and Lomb PreservisionThere are many eye vitamins available today using the AREDS formula and variations of it. With so many options, it can be confusing. Ask your eye doctor which formula is best for you and have the name of the eye supplement written down before you go to the store.Bausch and Lomb PreserVision is an eye vitamin that comes in two varieties - one that uses the original AREDS formula and a AREDS vitamins with lutein (minus the beta-carotene for smokers). The recommended dosage is to take two eye supplements a day. One in the morning and one in the evening with meals. Icaps VitaminsIcaps vitamins are made by the company Alcon, a global company based in Hünenberg, Switzerland.The Icaps AREDS Formula The recommended dosage is two soft gels per day. One bottle lasts a month and costs around $12. Age Related Eye Disease Study 2 - AREDS 2The NEI has launched the Age-Related Eye Disease Study 2 (AREDS2). There are nearly 100 clinical centers with over 4,000 study participants ages 50 - 85 who have AMD.This study is no longer recruiting new participants but it is ongoing. Enrollment concluded in June 2008 and participants will be followed between five and six years. To learn more about this macular degeneration clinical trial click here:
AREDS 2
Loading Go from Age Related Eye Disease Study to Macular Degeneration Research
Would you like to be updated on: √ The Latest Macular Degeneration Clinical Trials? 
√ Prevention of Macular Degeneration?
√ Tips for Daily Living? √ Food Suggestions for a Macular Degeneration Diet? √ Ideas on Visual Aids to Maximize your Sight? If you said "yes" to any of the above, sign up for my monthly Macular Degeneration News. New! CommentsShare your thoughts about what you just read! Leave a comment in the box below. |
contains the same dosage of vitamins and minerals used in the Age-Related Eye Disease Study (AREDS) by the National Eye Institute (NEI).